Mri and targeted biopsy essential tools for an accurate diagnosis and treatment decision making in prostate cancer

Suraj Samtani; Mauricio Burotto; Juan Carlos Roman; Daniela Cortes-Herrera; Annerleim Walton-Diaz

doi:10.3390/diagnostics11091551

Mri and targeted biopsy essential tools for an accurate diagnosis and treatment decision making in prostate cancer

Suraj Samtani, Mauricio Burotto, Juan Carlos Roman, Daniela Cortes-Herrera, Annerleim Walton-Diaz^*

^*Autor correspondiente de este trabajo

Clínica Universidad de los Andes

Producción científica: Contribución a una revista › Artículo de revisión › revisión exhaustiva

1 Cita (Scopus)

Resumen

Prostate cancer (PCa) is one of the most frequent causes of cancer death worldwide. Historically, diagnosis was based on physical examination, transrectal (TRUS) images, and TRUS biopsy resulting in overdiagnosis and overtreatment. Recently magnetic resonance imaging (MRI) has been identified as an evolving tool in terms of diagnosis, staging, treatment decision, and follow-up. In this review we provide the key studies and concepts of MRI as a promising tool in the diagnosis and management of prostate cancer in the general population and in challenging scenarios, such as anteriorly located lesions, enlarged prostates determining extracapsular extension and seminal vesicle invasion, and prior negative biopsy and the future role of MRI in association with artificial intelligence (AI).

Idioma original	Inglés
Número de artículo	1551
Publicación	Diagnostics
Volumen	11
N.º	9
DOI	https://doi.org/10.3390/diagnostics11091551
Estado	Publicada - 27 ago. 2021

Nota bibliográfica

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.3390/diagnostics11091551

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{5e829a4edd194665b2a38249f1eb5a02,

title = "Mri and targeted biopsy essential tools for an accurate diagnosis and treatment decision making in prostate cancer",

abstract = "Prostate cancer (PCa) is one of the most frequent causes of cancer death worldwide. Historically, diagnosis was based on physical examination, transrectal (TRUS) images, and TRUS biopsy resulting in overdiagnosis and overtreatment. Recently magnetic resonance imaging (MRI) has been identified as an evolving tool in terms of diagnosis, staging, treatment decision, and follow-up. In this review we provide the key studies and concepts of MRI as a promising tool in the diagnosis and management of prostate cancer in the general population and in challenging scenarios, such as anteriorly located lesions, enlarged prostates determining extracapsular extension and seminal vesicle invasion, and prior negative biopsy and the future role of MRI in association with artificial intelligence (AI).",

keywords = "Active surveillance, Artificial intelligence, Diagnosis, MRI, Prostate cancer",

author = "Suraj Samtani and Mauricio Burotto and Roman, {Juan Carlos} and Daniela Cortes-Herrera and Annerleim Walton-Diaz",

note = "Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2021",

month = aug,

day = "27",

doi = "10.3390/diagnostics11091551",

language = "English",

volume = "11",

journal = "Diagnostics",

issn = "2075-4418",

publisher = "MDPI AG",

number = "9",

}

TY - JOUR

T1 - Mri and targeted biopsy essential tools for an accurate diagnosis and treatment decision making in prostate cancer

AU - Samtani, Suraj

AU - Burotto, Mauricio

AU - Roman, Juan Carlos

AU - Cortes-Herrera, Daniela

AU - Walton-Diaz, Annerleim

PY - 2021/8/27

Y1 - 2021/8/27

N2 - Prostate cancer (PCa) is one of the most frequent causes of cancer death worldwide. Historically, diagnosis was based on physical examination, transrectal (TRUS) images, and TRUS biopsy resulting in overdiagnosis and overtreatment. Recently magnetic resonance imaging (MRI) has been identified as an evolving tool in terms of diagnosis, staging, treatment decision, and follow-up. In this review we provide the key studies and concepts of MRI as a promising tool in the diagnosis and management of prostate cancer in the general population and in challenging scenarios, such as anteriorly located lesions, enlarged prostates determining extracapsular extension and seminal vesicle invasion, and prior negative biopsy and the future role of MRI in association with artificial intelligence (AI).

AB - Prostate cancer (PCa) is one of the most frequent causes of cancer death worldwide. Historically, diagnosis was based on physical examination, transrectal (TRUS) images, and TRUS biopsy resulting in overdiagnosis and overtreatment. Recently magnetic resonance imaging (MRI) has been identified as an evolving tool in terms of diagnosis, staging, treatment decision, and follow-up. In this review we provide the key studies and concepts of MRI as a promising tool in the diagnosis and management of prostate cancer in the general population and in challenging scenarios, such as anteriorly located lesions, enlarged prostates determining extracapsular extension and seminal vesicle invasion, and prior negative biopsy and the future role of MRI in association with artificial intelligence (AI).

KW - Active surveillance

KW - Artificial intelligence

KW - Diagnosis

KW - MRI

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=85114040042&partnerID=8YFLogxK

U2 - 10.3390/diagnostics11091551

DO - 10.3390/diagnostics11091551

M3 - Review article

C2 - 34573893

AN - SCOPUS:85114040042

SN - 2075-4418

VL - 11

JO - Diagnostics

JF - Diagnostics

IS - 9

M1 - 1551

ER -

Mri and targeted biopsy essential tools for an accurate diagnosis and treatment decision making in prostate cancer

Resumen

Nota bibliográfica

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto